Pathways to Prevention (P2P) Program

Marc C. Hochberg, M.D., M.P.H., MACP, MACR

Marc C. Hochberg, M.D., M.P.H., MACP, MACR

Professor of Medicine and Epidemiology and Public Health
Department of Medicine
University of Maryland School of Medicine
Veterans Affairs Maryland Health Care System

Marc Hochberg received his M.D. and M.P.H. from The Johns Hopkins University School of Medicine and School of Hygiene and Public Health, respectively. He completed residency training in internal medicine and fellowship training in rheumatology at The Johns Hopkins Hospital. He was a member of the faculty of The Johns Hopkins University School of Medicine from 1977 to 1991. He is Professor of Medicine and Epidemiology and Public Health, Head of the Division of Rheumatology and Clinical Immunology, and Vice Chair of the Department of Medicine at the University of Maryland School of Medicine. In 2014, he assumed the position of Director, Medical Care Clinical Center for the VA Maryland Health Care System.

Dr. Hochberg received the Clinical Research Award from the Osteoarthritis Research Society International (OARSI) in 1999, was named 1 of only 50 “Postdoctoral Fellow Heroes” by the Arthritis Foundation in 2001. He received the Mary Betty Stevens Clinical Research Award from the American College of Physicians (Maryland Chapter) in 2002, the Roger Demers Prize at the 42nd Laurentian Conference of Rheumatology in 2011, the Distinguished Clinical Investigator Award from the American College of Rheumatology (ACR) in 2012, the Lifetime Achievement Award from OARSI in 2013, the Art Modell Presidents Award from the Arthritis Foundation, Maryland Chapter in 2013, and the Distinguished Alumnus Award from both Franklin & Marshall College and The Johns Hopkins University in 2014. He also was named a Master of both the American College of Physicians and the American College of Rheumatology in 2014.

He presently serves as President, U.S. Bone and Joint Initiative. He was General Secretary and a member of the Board of Directors of OARSI, a member of the Board of Directors of both the ACR and the ACR Research and Education Foundation, a member of the Board of Directors of the U.S. Bone and Joint Initiative, and Chair, Standing Committee on Epidemiology of the International League of Associations of Rheumatology. 

Dr. Hochberg has published over 400 peer-reviewed articles and 60 book chapters, and is an Editor of the textbooks Rheumatology, 7th edition (Mosby/Elsevier, 2019), Epidemiology of the Rheumatic Diseases, 2nd edition (Oxford University Press, 2001), and Rheumatoid Arthritis (Mosby/Elsevier, 2009). He is currently Editor-in-Chief of Seminars in Arthritis and Rheumatism.

Dr. Hochberg’s research focuses on the clinical epidemiology of musculoskeletal disorders, particularly osteoarthritis and hip fracture. He is Principal Investigator of the Baltimore Clinical Center for the Osteoarthritis Initiative and Co-Principal Investigator of the Baltimore Hip Studies; he was formerly the Principal Investigator for the Baltimore Clinical Center of the Study of Osteoporotic Fractures and several multicenter clinical trials of bisphosphonates for osteoporosis. His current research is funded by the NIH.

Dr. Hochberg disclosed the following conflicts of interest for this workshop:

  • I receive research support from the National Institutes of Health.
  • I serve as a consultant to Eli Lilly, EMD Serono, Novartis Pharma AG, Pfizer Inc., Roche and Samumed LLC.
  • I serve on the Medical Advisory Board of and own stock in Theralogix LLC.
  • I receive royalties from Elsevier.
  • I serve as President, U.S. Bone and Joint Initiative.

Return to the Workshop Agenda

 

Last updated on